Cardiol Therapeutics (CRTPF) News Today $1.82 -0.04 (-2.15%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cardiol Therapeutics Faces Rising Losses and Falling AssetsNovember 16 at 12:16 AM | markets.businessinsider.comInside the production pipeline for new drugs to combat heart failureSeptember 14, 2024 | msn.comCardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart DiseaseAugust 22, 2024 | seekingalpha.comCardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of PericarditisFebruary 15, 2024 | finance.yahoo.comCardiol Therapeutics Fights Heart Inflammation With Novel FormulationsOctober 12, 2023 | benzinga.comCardiol Therapeutics Inc. (CRDL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?September 13, 2023 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc flat on Friday (CRDL)August 26, 2023 | theglobeandmail.comCardiol Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CRDL)August 18, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc flat on Monday (CRDL)August 14, 2023 | theglobeandmail.comCardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital MarketAugust 8, 2023 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc up on Thursday (CRDL)April 20, 2023 | theglobeandmail.comHere's Why Cardiol Therapeutics Inc. (CRDL) Could be Great Choice for a Bottom FisherNovember 11, 2022 | nasdaq.comCardiol Therapeutics Inc. (CRDL)September 24, 2022 | uk.finance.yahoo.comCardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of DirectorsMay 19, 2022 | stockhouse.comCardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory BoardJanuary 19, 2022 | finance.yahoo.comCardiol Therapeutics Inc - Class A Shares Close the Day 16.3% Higher - Daily WrapJanuary 16, 2022 | nasdaq.comCardiol Therapeutics IncNovember 3, 2021 | reuters.comCardiol Therapeutics Shares Drop After Unit Offering PricesNovember 3, 2021 | marketwatch.comCardiol Therapeutics Inc. (CRDL) Could Find Support Soon, Here's Why You Should Buy the Stock NowOctober 26, 2021 | nasdaq.comCardiol Therapeutics Expanding LANCER Trial, Shares Trading HigherOctober 18, 2021 | marketwatch.comWhen Will Cardiol Therapeutics Inc. (TSE:CRDL) Turn A Profit?August 19, 2021 | finance.yahoo.comBRIEF-Cardiol Therapeutics To Commence Trading On Nasdaq Under Symbol "CRDL"August 9, 2021 | msn.comCardiol Therapeutics receives final approval to list its common...August 9, 2021 | proactiveinvestors.comCardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol "CRDL"August 9, 2021 | finance.yahoo.comCardiol Therapeutics Inc.August 6, 2021 | barrons.com Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTPF and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. CRTPF Media Mentions By Week CRTPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRTPF News Sentiment▼-1.020.57▲Average Medical News Sentiment CRTPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRTPF Articles This Week▼10▲CRTPF Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Algernon Pharmaceuticals News Allstar Health Brands News Alvotech News American Premium Mining News Anew Medical News Arno Therapeutics News AstraZeneca News AVVAA World Health Care Products News Basilea Pharmaceutica News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CRTPF) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
